AUS
NZ
UK
CA
USA
IND
Healt
Pro Medicus (ASX:PME): Why Is Its Latest AI Move Turning Heads?
June 25, 2026 11:09 AM AEST| By SamPro Medicus has expanded its healthcare technology strategy through a strategic AI collaboration designed to strengthen its enterprise imaging ecosystem and support advanced cardiac imaging capabilities.
Syntara (ASX:SNT): Why Is the Biotech Company Expanding Its Listed Shares?
June 25, 2026 10:48 AM AEST| By SamSyntara has applied to quote additional ordinary shares on the ASX, supporting its capital management strategy while continuing to advance research activities within Australia's biotechnology sector.
Sigma Healthcare (ASX:SIG): Why Has This Healthcare Giant Suddenly Lost Market Momentum?
June 25, 2026 09:47 AM AEST| By SamSigma Healthcare remained under market scrutiny after recent share price weakness, while merger integration, pharmacy network expansion, escrow milestones and disciplined Australian growth strategy continued shaping market sentiment.
The 10 Richest People in Australia: The Billionaires Shaping Mining, Property, Tech and Business
June 24, 2026 07:07 PM AEST| By Shwetambri ChauhanHighlightsAustralia's wealthiest individuals have built their fortunes across diverse sectors, moving beyond traditional mining to include global software powerhouses and advanced manufacturing.Resource sector dominance remains steadfast, with figures like Gina Rinehart and Andrew Forrest capitalising on the sustained global demand for iron ore and …
Pro Medicus (ASX:PME): The Contract Signal Reshaping Healthcare Stocks
June 24, 2026 10:10 PM AEST| By SamMedical imaging software contracts are becoming a critical healthcare sector signal as investors focus on execution, cash-flow quality and company-specific performance, with Pro Medicus emerging as a central name in the discussion.
Healthcare Stocks: Why (ASX:CSL) Is at the Centre of the Valuation Reset
June 24, 2026 10:05 PM AEST| By SamHealthcare stocks are facing greater scrutiny as markets focus on valuation, cash flow and execution. CSL, Pro Medicus, Cochlear and ResMed illustrate why company-specific performance is becoming more important than broad sector labels.
CSL Share Price ASX: Is the Biotech Giant Finally Finding a Floor?
June 24, 2026 06:15 PM AEST| By SamCSL share price ASX searches are rising as the healthcare giant rebounds from heavy pressure, with market focus on earnings clarity, divisional performance and confidence repair.
Betashares Australian Government Bond ETF Exchange Traded Fund Units (AGVT): Fund Overview, Performance, and Key Facts
June 24, 2026 06:38 PM AEST| By Shwetambri Chauhan
Why Are CSL (ASX:CSL) Shares Rebounding After Heavy Selloff?
June 24, 2026 01:26 PM AEST| By SamCSL (ASX:CSL) has rebounded after a steep healthcare selloff, with investors reassessing valuation resets, revised guidance and long-term structural strengths.
![Is [ASX 200] Cochlear (ASX:COH) Facing Its Biggest Test Yet?](https://kalkinemedia.com/storage/uploads/thumbnail/Biotechnology_06_24_2026_03_47_15_321502.jpg)
Is [ASX 200] Cochlear (ASX:COH) Facing Its Biggest Test Yet?
June 24, 2026 01:26 PM AEST| By SamCochlear faces heightened scrutiny after a major guidance downgrade triggered a sharp market reaction, raising questions about valuation, execution and growth while keeping the healthcare leader firmly in focus.
Is RMD (ASX:RMD) Leading a Healthcare Turnaround Signal?
June 24, 2026 01:26 PM AEST| By SamResMed (ASX:RMD) is in focus as ASX healthcare remains under pressure, with investors debating whether the sector’s selloff has gone beyond fundamentals.
Betashares Global Quality Leaders ETF (QLTY): Fund Overview, Performance, and Key Facts
June 24, 2026 06:38 PM AEST| By Shwetambri ChauhanKey Takeaways
CSL (ASX:CSL) Shares Under Pressure: What Is Driving the Weakness?
June 24, 2026 10:03 AM AEST| By SamCSL continues attracting attention as market participants evaluate healthcare demand, earnings recovery efforts, operational execution and the performance of its broader healthcare portfolio.
Why Is CSL (ASX:CSL) Under Pressure as Its Biggest Reset Takes Shape?
June 24, 2026 04:14 AM AEST| By SamCSL remains one of Australia's most closely watched healthcare companies as restructuring, leadership changes and operational improvements shape a significant transformation phase.
Is Cochlear (ASX:COH) Facing Its Toughest Test Yet After a Deep Earnings Shock?
June 24, 2026 04:14 AM AEST| By SamCochlear faces renewed market scrutiny as delayed procedures, weaker referrals and softer demand affect performance, while its global healthcare franchise, installed base and innovation capabilities continue supporting long-term relevance.
BetaShares FTSE RAFI Australia 200 ETF (QOZ): Fund Overview, Performance, and Key Facts
June 24, 2026 06:38 PM AEST| By Shwetambri ChauhanKey Takeaways
What Could Put CSL (ASX:CSL) Back in the Healthcare Spotlight?
June 24, 2026 04:14 AM AEST| By SamASX healthcare shares remain under pressure as CSL, Cochlear and ResMed face valuation resets, earnings scrutiny and shifting market sentiment after a difficult sector rotation.
CSL (ASX:CSL) and ASX Healthcare Stocks: Is the Defensive Premium Returning?
June 23, 2026 09:19 PM AEST| By SamHealthcare stocks are facing a renewed market test as attention shifts towards earnings quality, margin recovery and cash generation. CSL, ResMed and Sonic Healthcare remain central to the debate over whether defensive healthcare can rebuild market c...
Why Pro Medicus (ASX:PME) and Telix Are Driving Healthcare Buzz
June 23, 2026 09:10 PM AEST| By SamSpecialist healthcare companies focused on imaging technology and radiopharmaceutical innovation are attracting renewed attention as markets prioritise operational delivery, clinical adoption, cash generation and sustainable business performance.
BetaShares Gold Bullion ETF - Currency Hedged (QAU): Fund Overview, Performance, and Key Facts
June 24, 2026 06:37 PM AEST| By Shwetambri ChauhanKey Takeaways
Monash IVF (ASX:MVF): Why This Healthcare Dividend Stock Faces a New Test
June 23, 2026 11:42 AM AEST| By SamMonash IVF remains under the spotlight as industry activity trends and broader economic conditions influence Australia's fertility services market.
Tetratherix (ASX:TTX): Why Is This Healthcare Stock Expanding Its Share Base?
June 23, 2026 10:56 AM AEST| By SamTetratherix has completed the quotation of additional shares on the ASX, reflecting ongoing capital management while continuing to advance its healthcare technology focus.
Singular Health (ASX:SHG): What’s Behind the New Share Quotation Move?
June 23, 2026 10:49 AM AEST| By SamSingular Health has applied to quote newly issued shares while continuing to advance its digital healthcare and medical imaging technology solutions.
VanEck Australian Floating Rate ETF (FLOT): Fund Overview, Performance, and Key Facts
June 24, 2026 06:37 PM AEST| By Shwetambri ChauhanKey Takeaways
CSL (ASX:CSL) or ResMed (ASX:RMD): Which Healthcare Giant Is Back in the Spotlight?
June 23, 2026 10:10 AM AEST| By SamCSL and ResMed remain closely watched healthcare leaders as long-term demand trends, innovation and global healthcare needs continue shaping the sector.
CSL, ResMed and Cochlear: Is Healthcare’s Comeback Just Beginning?
June 22, 2026 09:19 PM AEST| By SamHealthcare stocks are re-entering focus as defensive growth themes strengthen. CSL, ResMed and Cochlear highlight how company execution, cash-flow quality and sector resilience are shaping the latest healthcare recovery conversation.
Advertise your brand on Kalkine Media